Table 5.
Clinical characteristics of patients with subdivided basal insulin group.
| Basal Insulin | HbA1c<7% (N=69) |
HbA1c≥7% (N=130) |
p value |
|---|---|---|---|
| Age (years) | 59.64 ± 10.22 | 59.28 ± 12.71 | 0.83 |
| Fasting C-peptide (ng/ml) | 1.20 ± 0.08 | 1.20 ± 0.10 | 0.98 |
| Ins-Ab (COI) | 7.7 ± 0.99 | 9.12 ± 1.32 | 0.39 |
| Duration of T2DM (years) | 14.24 ± 6.02 | 13.21 ± 6.13 | 0.25 |
| Duration of insulin (years) | 5.76 ± 3.12 | 5.20 ± 3.18 | 0.22 |
| Insulin dose (IU/kg/day) | 0.28 ± 0.08 | 0.32 ± 0.13 | 0.12 |
Data was shown as mean ± SD. HbA1c, glycated haemoglobin; Ins-Ab, insulin antibody; COI, OD/CO; OD, absorbance; CO, average absorbance of negative control; The reference range of normal values for antibody is <1 COI.